Literature DB >> 24957587

An unusual case of bowel perforation.

Roxana Elena Lazarescu1, Kelley Bohm1.   

Abstract

Bowel perforation is a potentially fatal complication of obstruction, ischaemia, trauma, surgery and medications. It is recognised by clinical suspicion based on history, symptoms of severe abdominal pain and signs such as rebound tenderness, as well as imaging showing free air in the abdomen. Bevacizumab (aka avastin) is an antineoplastic recombinant monoclonal antibody that inhibits angiogenesis in a variety of malignancies. Colonic perforation is a recognised but rare complication of this therapy, likely due to aforementioned bowel ischaemia or compromised mucosal microcirculation which increases susceptibility to injury. We are presenting a case of an unrecognised bowel perforation caused in a patient with abdominal carcinomatosis. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24957587      PMCID: PMC4069698          DOI: 10.1136/bcr-2014-204643

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  1 in total

Review 1.  Bevacizumab-induced bowel perforation.

Authors:  Sarunas Sliesoraitis; Bernard Tawfik
Journal:  J Am Osteopath Assoc       Date:  2011-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.